We propose that NKG7 exerts the same function in cytotoxic CD4+ T cells including TFK cells, leading to GZMK-mediated complement activation or GZMB-mediated activation-induced cell death of target – possibly lymphoma – cells. The gene discussed is GZMK; the disease is lymphoma.